glp-1 colorectal cancer death risk study november 2025 Could medications help slow progression?⁣ ⁣ A new Cleveland Clinic found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to ASCO GI 2026: GLP-1 receptor

Induction of CYP1A1, CYP1A2, CYP1B1, increased oxidative stress and inflammation in the lung and liver tissues of rats exposed to incense smoke

BHRC uses bioidentical hormones exclusively for more predictable responses and the ability to compound precise, individualized doses

If you plan to drink or have a history of alcohol abuse or prescription drug abuse in your family, its important to discuss alternative treatment options with your doctor

The mass resolution was 120,000 and the automatic gain control (AGC) target was 3 10 6

The ones promising rapid transformation are the ones most likely to leave you searching for answers at 2am